Enzyme Poly ADP Ribose Polymerase Inhibitor Market - Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: E1A0A399614EEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Enzyme Poly ADP Ribose Polymerase Inhibitor in Global, including the following market information:

Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Enzyme Poly ADP Ribose Polymerase Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Niraparib (Zejula) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Enzyme Poly ADP Ribose Polymerase Inhibitor include AstraZeneca, Pfizer, Takeda, Abbvie, Clovis, BeiGene, Hansoh, Jeil and Oncology and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Enzyme Poly ADP Ribose Polymerase Inhibitor companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Segment Percentages, by Type, 2021 (%)

• Niraparib (Zejula)
• Olaparib (Lynparza)
• Rucaparib (Rubraca)
• Talazoparib (Talzenna)

Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Enzyme Poly ADP Ribose Polymerase Inhibitor revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Enzyme Poly ADP Ribose Polymerase Inhibitor revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AstraZeneca
• Pfizer
• Takeda
• Abbvie
• Clovis
• BeiGene
• Hansoh
• Jeil
• Oncology
• Shin Poong

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Enzyme Poly ADP Ribose Polymerase Inhibitor Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ENZYME POLY ADP RIBOSE POLYMERASE INHIBITOR OVERALL MARKET SIZE

2.1 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size: 2021 VS 2028
2.2 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Enzyme Poly ADP Ribose Polymerase Inhibitor Players in Global Market
3.2 Top Global Enzyme Poly ADP Ribose Polymerase Inhibitor Companies Ranked by Revenue
3.3 Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue by Companies
3.4 Top 3 and Top 5 Enzyme Poly ADP Ribose Polymerase Inhibitor Companies in Global Market, by Revenue in 2021
3.5 Global Companies Enzyme Poly ADP Ribose Polymerase Inhibitor Product Type
3.6 Tier 1, Tier 2 and Tier 3 Enzyme Poly ADP Ribose Polymerase Inhibitor Players in Global Market
  3.6.1 List of Global Tier 1 Enzyme Poly ADP Ribose Polymerase Inhibitor Companies
  3.6.2 List of Global Tier 2 and Tier 3 Enzyme Poly ADP Ribose Polymerase Inhibitor Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size Markets, 2021 & 2028
  4.1.2 Niraparib (Zejula)
  4.1.3 Olaparib (Lynparza)
  4.1.4 Rucaparib (Rubraca)
  4.1.5 Talazoparib (Talzenna)
4.2 By Type - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue & Forecasts
  4.2.1 By Type - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2017-2022
  4.2.2 By Type - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2023-2028
  4.2.3 By Type - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue & Forecasts
  5.2.1 By Application - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2017-2022
  5.2.2 By Application - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2023-2028
  5.2.3 By Application - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2021 & 2028
6.2 By Region - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue & Forecasts
  6.2.1 By Region - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2017-2022
  6.2.2 By Region - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2023-2028
  6.2.3 By Region - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2017-2028
  6.3.2 US Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.3.3 Canada Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.3.4 Mexico Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2017-2028
  6.4.2 Germany Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.4.3 France Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.4.4 U.K. Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.4.5 Italy Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.4.6 Russia Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.4.7 Nordic Countries Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.4.8 Benelux Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2017-2028
  6.5.2 China Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.5.3 Japan Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.5.4 South Korea Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.5.5 Southeast Asia Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.5.6 India Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2017-2028
  6.6.2 Brazil Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.6.3 Argentina Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2017-2028
  6.7.2 Turkey Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.7.3 Israel Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.7.4 Saudi Arabia Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028
  6.7.5 UAE Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.1.4 AstraZeneca Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.1.5 AstraZeneca Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.2.4 Pfizer Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Takeda
  7.3.1 Takeda Corporate Summary
  7.3.2 Takeda Business Overview
  7.3.3 Takeda Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.3.4 Takeda Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.3.5 Takeda Key News
7.4 Abbvie
  7.4.1 Abbvie Corporate Summary
  7.4.2 Abbvie Business Overview
  7.4.3 Abbvie Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.4.4 Abbvie Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.4.5 Abbvie Key News
7.5 Clovis
  7.5.1 Clovis Corporate Summary
  7.5.2 Clovis Business Overview
  7.5.3 Clovis Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.5.4 Clovis Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.5.5 Clovis Key News
7.6 BeiGene
  7.6.1 BeiGene Corporate Summary
  7.6.2 BeiGene Business Overview
  7.6.3 BeiGene Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.6.4 BeiGene Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.6.5 BeiGene Key News
7.7 Hansoh
  7.7.1 Hansoh Corporate Summary
  7.7.2 Hansoh Business Overview
  7.7.3 Hansoh Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.7.4 Hansoh Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.7.5 Hansoh Key News
7.8 Jeil
  7.8.1 Jeil Corporate Summary
  7.8.2 Jeil Business Overview
  7.8.3 Jeil Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.8.4 Jeil Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.8.5 Jeil Key News
7.9 Oncology
  7.9.1 Oncology Corporate Summary
  7.9.2 Oncology Business Overview
  7.9.3 Oncology Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.9.4 Oncology Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.9.5 Oncology Key News
7.10 Shin Poong
  7.10.1 Shin Poong Corporate Summary
  7.10.2 Shin Poong Business Overview
  7.10.3 Shin Poong Enzyme Poly ADP Ribose Polymerase Inhibitor Major Product Offerings
  7.10.4 Shin Poong Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global Market (2017-2022)
  7.10.5 Shin Poong Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Enzyme Poly ADP Ribose Polymerase Inhibitor Market Opportunities & Trends in Global Market
Table 2. Enzyme Poly ADP Ribose Polymerase Inhibitor Market Drivers in Global Market
Table 3. Enzyme Poly ADP Ribose Polymerase Inhibitor Market Restraints in Global Market
Table 4. Key Players of Enzyme Poly ADP Ribose Polymerase Inhibitor in Global Market
Table 5. Top Enzyme Poly ADP Ribose Polymerase Inhibitor Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Share by Companies, 2017-2022
Table 8. Global Companies Enzyme Poly ADP Ribose Polymerase Inhibitor Product Type
Table 9. List of Global Tier 1 Enzyme Poly ADP Ribose Polymerase Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Enzyme Poly ADP Ribose Polymerase Inhibitor Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2023-2028
Table 30. AstraZeneca Corporate Summary
Table 31. AstraZeneca Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 32. AstraZeneca Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 35. Pfizer Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 36. Takeda Corporate Summary
Table 37. Takeda Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 38. Takeda Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 39. Abbvie Corporate Summary
Table 40. Abbvie Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 41. Abbvie Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 42. Clovis Corporate Summary
Table 43. Clovis Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 44. Clovis Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 45. BeiGene Corporate Summary
Table 46. BeiGene Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 47. BeiGene Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 48. Hansoh Corporate Summary
Table 49. Hansoh Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 50. Hansoh Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 51. Jeil Corporate Summary
Table 52. Jeil Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 53. Jeil Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 54. Oncology Corporate Summary
Table 55. Oncology Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 56. Oncology Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)
Table 57. Shin Poong Corporate Summary
Table 58. Shin Poong Enzyme Poly ADP Ribose Polymerase Inhibitor Product Offerings
Table 59. Shin Poong Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Enzyme Poly ADP Ribose Polymerase Inhibitor Segment by Type in 2021
Figure 2. Enzyme Poly ADP Ribose Polymerase Inhibitor Segment by Application in 2021
Figure 3. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue in 2021
Figure 8. By Type - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028
Figure 9. By Application - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028
Figure 10. By Region - Global Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028
Figure 11. By Country - North America Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028
Figure 12. US Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028
Figure 16. Germany Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 17. France Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028
Figure 24. China Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 28. India Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028
Figure 30. Brazil Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Market Share, 2017-2028
Figure 33. Turkey Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue, (US$, Mn), 2017-2028
Figure 37. AstraZeneca Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Takeda Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbvie Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Clovis Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. BeiGene Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Hansoh Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Jeil Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Oncology Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Shin Poong Enzyme Poly ADP Ribose Polymerase Inhibitor Revenue Year Over Year Growth (US$, Mn) & (2017-2022)